NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons

NeuroToxicology

Volumn 33, Issue 3, 2012, Pages 429-435

  Munhall, Adam C ^a   Wu, Yan Na ^a   Belknap, John K ^a,b   Meshul, Charles K ^a,b   Johnson, Steven W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Dendrite; Histology; N methyl d aspartate; Rotenone; Substantia nigra; Ventral tegmental area

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; ROTENONE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL DENSITY; CONTROLLED STUDY; DENDRITE; DOPAMINERGIC NERVE CELL; DRUG ACTIVITY; DRUG POTENCY; HISTOPATHOLOGY; MALE; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM;

ANIMALS; CYTOPROTECTION; DENDRITES; DOPAMINE; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MALE; N-METHYLASPARTATE; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

RATTUS;

EID: 84861185702     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.04.006     Document Type: Article

References (37)

1. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3:1301-1306.
2. Bywood P.T., Johnson S.M. Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices. Exp Neurol 2000, 161:306-316.
3. Bywood P.T., Johnson S.M. Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices. Exp Neurol 2003, 179:47-59.
4. Chatha B.T., Bernard V., Streit P., Bolam J.P. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra. Neuroscience 2000, 101:1037-1051.
5. Gibb W.R.G., Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991, 54:388-396.
6. Grabb M.C., Choi D.W. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J Neurosci 1999, 19:1657-1662.
7. Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002, 5:405-414.
8. Hattori N., Tanaka M., Ozawa T., Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 1991, 30:563-571.
9. Jiang Q., Yan Z., Feng J. Neurotrophic factors stabilize microtubules and protect against rotenone toxicity on dopaminergic neurons. J Biol Chem 2006, 281:29391-29400.
10. Jiang X., Tian F., Mearow K., Okagaki P., Lipsky R.H., Marini A.M. The excitoprotective effect of N-methyl-d-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J Neurochem 2005, 94:713-722.
11. Johnson S.M., Bywood P.T. Degeneration of the dendritic arbor as an index of neurotoxicity in identified catecholamine neurons in rat brain slices. Exp Neurol 1998, 151:221-228.
12. Jones S., Gibb A.J. Functional NR2B- NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones. J Physiol (Lond) 2005, 569:209-221.
13. Kress G.J., Reynolds I.J. Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures. Neurobiol Dis 2005, 20:639-645.
14. 2+ block in NMDA receptor channels. J Neurosci 1996, 16:3549-3558.
15. Lin Y.-F., Raab-Graham K., Jan Y.N., Jan L.Y. NO stimulation of ATP-sensitive potassium channels: involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection. Proc Natl Acad Sci USA 2004, 101:7799-7804.
16. Loudes C., Petit F., Kordon C., Faivre-Bauman A. Distinct populations of hypothalamic dopaminergic neurons exhibit differential responses to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3). Eur J Neurosci 1999, 11:617-624.
17. Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H.V., Marsden C.D. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992, 115:333-342.
18. Marey-Semper I., Gelman M., Levi-Strauss M. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergic effects of energetic metabolism impairment and NMDA receptor activation. J Neurosci 1995, 15:5912-5918.
19. Marini A.M., Paul S.M. N-methyl-d-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc Natl Acad Sci USA 1992, 89:6555-6559.
20. Papadia S., Soriano F.X., Léveillé F., Martel M.-A., Dakin K.A., Hansen H.H., et al. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 2008, 11:476-487.
21. Paquet M., Tremblay M., Soghomonian J.-J., Smith Y.A.M.P.A NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci 1997, 17:1377-1396.
22. Parker W.D., Boyson S.J., Parks J.K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989, 26:719-723.
23. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, San Diego.
24. Puche A.C., Shipley M.T. Pulse application of NMDA stimulates tyrosine hydroxylase expression in olfactory bulb neurons in vitro. They were interested in how exposure to natural odorants result in upregulation of TH, which can be blocked by AP-5 or APV. J Neurosci 1999, 19:1359-1370.
25. Sherer T.B., Betarbet R., Testa C.M., Seo B.B., Richardson J.R., Kim J.H., et al. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 2003, 23:10756-10764.
26. Sherer T.B., Kim J.-H., Betarbet R., Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp Neurol 2003, 179:9-16.
27. Sherer T.B., Trimmer P.A., Borland K., Parks J.K., Bennett J.P., Tuttle J.B. Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Res 2001, 891:94-105.
28. Shpargel K.B., Jalabi W., Min Y., Dadabayev A., Penn M.S., Trapp B.D. Preconditioning paradigms and pathways in the brain. Cleve Clin J Med 2008, 75(Suppl. 2):S77-S80.
29. Sokal R.R., Rohlf F.J. Biometry: the principles and practice of statistics in biological research 1995, W.H. Freeman and Co, New York.
30. Soriano F.X., Papadia S., Hofmann F., Hardingham N.R., Bading H., Hardingham G.E. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci 2006, 26:4509-4518.
31. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem 1992, 59:99-106.
32. Studer L., Spenger C., Seiler R.W., Othberg A., Lindvall O., Odin P. Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon. Exp Brain Res 1996, 108:328-336.
33. 3H]dihydrorotenone. J Neurochem 2000, 75:2611-2621.
34. Wu Y.-N., Johnson S.W. Rotenone potentiates NMDA currents in substantia nigra dopamine neurons. Neurosci Lett 2007, 421:96-100.
35. 2+-dependent block of NMDA currents in substantia nigra dopamine neurons. Neurotoxicology 2009, 30:320-325.
36. Wu Y.-N., Martella G., Johnson S.W. Rotenone enhances NMDA currents by activating a tyrosine kinase in rat dopamine neurons. Neuroreport 2007, 18:1813-1816.
37. Zhang Q.-G., Wang R.-M., Han D., Yang L.-C., Li J., Brann D.W. Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk. Neurosci Res 2009, 63:205-212.